TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24 July 3, 1981
TCL Archive OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB October 13, 1989